Tag: pharmaceuticals
-
Study: Longer Drug Exclusivity Hikes Costs, Adds Approvals
A new study in the January 2011 issue of the journal Health Affairs (paid subscription required) calculates the financial and social costs of regulations that limit access to pharmaceutical companies’ clinical trial data, used in the manufacture of generic drugs. The study suggests that extending the term of exclusive access for that data would likely…
-
Study: Pill Splitting Inaccurate, Potentially Dangerous
A study in the January 2011 issue of the Journal of Advanced Nursing (paid subscription required) suggests that the practice of cutting prescription tablets in half results in wide dosage variations, which can be dangerous for patients needing accurate doses of their medicines. The research was done by the Faculty of Pharmaceutical Sciences at Ghent…
-
Pharma, Biotech Ink Deal on Anti-Inflammatory Candidate
XOMA Ltd., a biotechnology company in Berkeley, California, and Les Laboratoires Servier a French pharmaceutical company, announced an agreement to develop and commercialize XOMA 052, XOMA’s anti-inflammatory drug candidate. XOMA 052 is designed to inhibit the pro-inflammatory cytokine interleukin-1 beta believed to be a primary trigger of pathologic inflammation in multiple diseases. Under the agreement,…
-
Biotech Licenses Natural Anti-Bacterial Compounds
AMRI, a biotechnology company in Albany, New York agreed to a research and licensing deal with Genentech, a Roche Group company, for AMRI’s anti-bacterial compounds from its natural products sample collection. Under the agreement, Genentech will receive an exclusive license to develop and commercialize potential products from AMRI’s anti-bacterial program. AMRI will also collaborate with…
-
Standards Proposed for Prescription Drug Labels
The U.S. Pharmacopeial Convention (USP), a standards–setting body for prescription and over–the–counter medicines, has prepared a set of standards to guide the content, language, format, and appearance of prescription medication labels in the U.S. The draft standards are open for a 90-day public comment period. USP says the standards, now in draft, reflect how patients…
-
Collaboration to Research Obesity Biomarkers, Drug Targets
Florida Hospital in Orlando, Sanford-Burnham Medical Research Institute also in Orlando, and Takeda Pharmaceutical Company in Osaka, Japan, will collaborate on developing new therapies for obesity, a growing worldwide health problem. The partnership aims to to identify and validate new obesity-related biomarkers and molecular targets. The project is the first corporate-sponsored research undertaken by the…
-
Survey: Type-2 Diabetes Patients Would Switch from Insulin
A new survey shows 60 percent of type-2 diabetes patients in the U.S. who currently use insulin say they would prefer switching to a less expensive bio-similar insulin if such an agent became available. Decision Resources, a health care industry research firm, conducted the survey of diabetes patients in September 2010. Decision Resources reports most…
-
Fund Established to Develop Cancer Vaccines
Cancer Research Institute (CRI) a not-for-profit organization in New York to advance the science of tumor immunology and discover new cancer therapies, launched today the Cancer Vaccine Acceleration Fund (CVAF), a new model of philanthropic investment and academic-industry collaboration. CRI established the fund with the Ludwig Institute for Cancer Research to encourage development of therapeutic…
-
Collaboration Researching Vaccine Against Malaria Parasite
The PATH Malaria Vaccine Initiative, Merck & Co. in Whitehouse Station, New Jersey, and NYU Langone Medical Center in New York are working on a new approach targeting a part of a major surface protein on the malaria parasite. The goal of the joint project is to develop a vaccine to prevent the malaria parasite…
-
Biotech Gets DARPA Grant for Respiratory Therapies
Pulmatrix, a biotechnology company in Lexington, Massachusetts, said today it received a grant for $5.7 million from the Defense Advanced Research Projects Agency (DARPA) in the Department of Defense, to further develop the company’s processes for the treatment and prevention of respiratory infections. DARPA identified Pulmatrix’s inhaled cationic airway lining modulators (iCALM) technology as a…